Clinuvel Pharmaceuticals (CUV.AU) Q1 2026 Earnings

Feb 25Confirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
0.19
0.29
0.39
0.49

Details

Expected EPS
0.27423661965895996
Actual EPS
0.19335010675056885
Surprise EPS
-0.08
Surprise Percent
-29.5%

Description

⁨Clinuvel Pharmaceuticals⁩ (⁦CUV.AU⁩) has reported earnings of ⁦0.19335010675056885⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts